ADHD and Racial Disparities: What Clinicians Can Do
- October 24, 2024
- The REACH Institute
- ADHD, Assessment & screening, Child mental health, Culturally responsive
“When a parent of color raises concerns about their child’s behavior, clinicians should always stop to assess for underlying disorders,” explains child and adolescent psychiatrist Brittainy Erby, MD. “I see many children and adolescents of color who have been diagnosed with a behavior disorder, but they actually have untreated ADHD.” The research reinforces what Dr.…
Untangling ADHD and Anxiety as Comorbidities
- June 25, 2024
- The REACH Institute
- ADHD, Anxiety, Assessment & screening, Child mental health
“ADHD and anxiety presenting together is very common in children and adolescents. But it can be difficult to discern which is the primary condition and which to treat first,” explains Kari Overstreet, DNP, APRN, CPNP-PC, PMHS, a pediatric nurse practitioner focused on child psychiatry and a Patient-Centered Mental Health in Pediatric Primary Care (PPP)…
How to help families awaiting an autism diagnosis
- November 20, 2023
- The REACH Institute
- ADHD, Autism, Patient communication
“Wait times to get a formal autism diagnosis from a qualified program range from six months to two years. It’s very frustrating for parents and their children who need services,” explains Dr. Mark Wolraich, MD, a REACH faculty member and retired professor of pediatrics at the University of Oklahoma Health Sciences Center.
Navigating the ADHD stimulant medication shortage
- October 31, 2023
- The REACH Institute
- ADHD, Child mental health, Parents, Patient communication
“The ADHD stimulant medication shortage is affecting patients, families, pharmacists, and clinicians,” explains Andrew Adesman, MD, a developmental pediatrician specializing in ADHD.
Supporting mental health needs in rural areas
- April 20, 2023
- The REACH Institute
- ADHD, Anxiety, Child mental health, Depression, Eating disorders, High-risk children & youth, LGBTQIA, Parents, Patient communication, Pediatric primary care
Rural healthcare providers can be overwhelmed—and understaffed with specialists. Discover how REACH inspired Elizabeth Wallis, M.D., to build a community to support her patients.
Is it ADHD? Or something else?
- December 14, 2022
- The REACH Institute
- ADHD, Assessment & screening, Child mental health
Attention-deficit hyperactivity disorder (ADHD) is one of the most common behavioral health disorders, affecting approximately 9% of all children and adolescents. About 75% of pediatric patients with ADHD have comorbid mental health conditions, ranging from oppositional-defiant disorder to anxiety and mood disorders.
What is a busy clinician to do? How do you discern whether a child who is, say, having difficulty focusing at school and at home has ADHD, anxiety, both, or something else?
IEP and 504 school accommodations for mental health needs
- July 12, 2022
- The REACH Institute
- ADHD, Anxiety, Child mental health Depression,
Children with mental health diagnoses may need special accommodations in order to succeed in school. Patients with attention-deficit hyperactivity disorder (ADHD) or autism come immediately to mind. However, children with depression and anxiety disorders may also struggle in the classroom.
Pediatric primary care providers (PCPs) and therapists can help families get the school accommodations their children need. Mark Wolraich, MD, REACH faculty member and retired professor of pediatrics at the University of Oklahoma Health Sciences Center, emphasizes that children are best served when professionals take a team approach to mental health care.
ADHD medication “holidays”?
- June 13, 2022
- The REACH Institute
- ADHD, Medication Parents,
As summer rolls around, families may ask whether their children can have a “holiday” from their psychoactive medication, especially for attention-deficit hyperactivity disorder (ADHD). We asked Lawrence Amsel, MD, MPH, a REACH faculty member and associate professor of psychiatry at Columbia University, to lay out the pros and cons.
New treatments for ADHD
- January 21, 2022
- The REACH Institute
- ADHD Medication,
Newer treatments approved by the Food and Drug Administration (FDA) for pediatric patients with attention-deficit/hyperactivity disorder (ADHD) include two medications that address some of the common issues families have with standard stimulant treatments. Another development is use of devices to manage ADHD symptoms.
Getting smarter about child mental health
- June 12, 2018
- The REACH Institute
- ADHD, Child mental health Medication,
“For these straightforward cases, when you can identify uncomplicated ADHD in patients without co-occuring depression or anxiety – well, everyone in primary care should be able to do this.”
Categories
- ADHD
- Anti-racism
- Anxiety
- Assessment & screening
- Autism
- Child mental health
- Coding
- Cognitive behavioral therapy
- College transition
- Culturally responsive
- Depression
- Eating disorders
- Foster care
- Grief
- High-risk children & youth
- LGBTQIA
- Medication
- Parents
- Patient communication
- Pediatric primary care
- School refusal
- Sleep disorders
- Suicide
- Trauma
- Show All Categories
Register for courses
“Every pediatric and family practice resident should be required to take this course! I will take away a renewed appreciation for assessment tools, a new comfort with treatment plans, and an excitement for future partnerships”